Posts Tagged

Swiss Re

Swiss Re in August 2019 announced it had acquired the UK closed book business of Quilter. The acquisition was made through Swiss Re’s specialized subsidiary ReAssure and includes Old Mutual Wealth Life Assurance and Old Mutual Wealth Pensions Trustees. Quilter is mostly comprised of companies belonging to the former Old Mutual group. It is active in investment consulting and asset management (GBP 45 billion in assets under management –

Swiss Re in May 2019 released its latest SONAR report, in which they highlight emerging and “slow-burner” emerging risks and their potential effects on the re/insurance industry. Emerging risks are newly developing or evolving risks that are difficult to quantify, but potentially have a significant impact on the industry and society. Emerging trend spotlights examine early development, which may offer both opportunities and risks for the insurance industry in

Emerging markets will remain the growth engine for the global economy and the insurance industry over the next decade, according to the latest sigma report from Swiss Re Institute, published in March 2019. The study explores how the seven largest emerging markets will contribute more than 40% of global growth in the next decade, with China accounting for over a quarter of the global output. (The seven largest emerging

Swiss Re in February 2019 reported it had realized an overall full-year net income of USD 421 million in 2018. The result includes estimated large claims of USD 3.0 billion, net of retrocession and before tax, which significantly affected both Property & Casualty Reinsurance (P&C Re) and Corporate Solutions’ segment earnings. In addition, an estimated pre-tax USD 599 million impact due to a change in US GAAP accounting guidance

Swiss Re in December 2018 appointed Paul Murray as Global Head of Life and Health, based in London, UK. He succeeds Swiss Re’s CEO of reinsurance for the EMEA region, Russell Higginbotham. Murray previously was global chief pricing officer for the L&H business; head of Swiss Re’s global L&H Products Center; managing director, Life & Health Products, Asia; managing director, Life & Health Products, UK, Ireland and Africa; director,

Swiss Re in August 2018 appointed Russell Higginbotham as CEO Reinsurance EMEA and Regional President EMEA; he joins the Group Executive Committee. He succeeds Jean-Jacques Henchoz, who leaves for Hannover Re. Russell Higginbotham most recently led Swiss Re’s global Life & Health (L&H) Products Division. Previously, he was CEO of Swiss Re UK & Ireland, CEO of Swiss Re Australia and New Zealand and led the company’s L&H businesses

Hannover Re in August 2018 announced Jean-Jacques Henchoz would become its CEO in May 2019 upon Ulrich Wallin’s retirement. Henchoz leads Swiss Re’s reinsurance division in Europe, Middle East and Africa (EMEA), having responsibility both for life and for non-life. Previously, he was Managing Director, Client Markets; led Swiss Re Canada as President & CEO; and held positions as Head of Strategic Planning for P&C; Underwriting Manager, Financial Reinsurance;

Swiss Re’s annual sigma report on premium volumes and growth trends for 2018 reveals that global life premiums increased to roughly USD 2.7 trillion in 2017, while global non-life premiums rose to about USD 2.2 trillion, while growth in both the life and non-life sectors slowed, partly due to falling life premiums in advanced markets such as the U.S. or Western Europe. Nevertheless, emerging markets remain an important driver

Swiss Re in June 2018 published its SONAR Report, which identifies emerging geopolitical risks, the re-emergence of asbestos, especially in high growth markets, and the risks arising from new technologies such as cyber risks, biased algorithms, and the erosion of risk diversification as some of the key risks facing the re/insurance industry as well as society at large. The SONAR report is a publication based on the SONAR process,

Swiss Re and SoftBank in May 2018 agreed to end discussions about a potential minority investment of SoftBank in Swiss Re. No explanation was given. However, SoftBank was originally considering a stake of up to 33%, as well as several seats on the Swiss Re board of directors, whilst Swiss Re said the holding would probably not exceed 10%. GBV had reported SoftBank’s push to increase its revenue stream

LifeScore Labs, a wholly owned subsidiary of U.S. insurance carrier Mass Mutual, and global reinsurer Swiss Re, have announced a collaboration to support LifeScore360, LifeScore Labs’ standards-based algorithmic risk scoring solution. LifeScore360 will be offered as an additional analytics option for Swiss Re’s automated underwriting system (Magnum). In addition, Swiss Re will more generally support the use of LifeScore360 in life reinsurance transactions in the U.S. LifeScore Labs was

Swiss Re in February 2018 announced it was in preliminary talks with Japanese conglomerate SoftBank, which could end up owning up to one-third of the global reinsurer. The deal is valued at around USD 10 billion. Other $10+ bn investments by SoftBank include Sprint (telecoms), ARM Holdings (microprocessors), Vodafone Japan (telecom), Didi Chuxing, Uber Technologies (both transportation); smaller investments in insurance include Lemonade. As to the rationale behind the

Swiss Re has appointed Urs Baertschi to the new position of President of Reinsurance, Latin America, reporting to Swiss Re Americas President and CEO Eric Smith and joining the company’s Americas Management Team. The appointment is effective January 1, 2016. Baertschi will split his time between Bogota, Mexico City, Miami and Sao Paulo offices. Previously, Baertschi was Managing Director, Head Principal Investments & Acquisitions Americas for Swiss Re and

Aon Benfield in September 2015 announced the appointment of Colin Dutkiewicz as Director of its Accident, Health and Life team, based in London and reporting to Roger Smith, Head of Aon Benfield’s Accident, Health and Life team. Colin joins Aon from Swiss Re, where he spent five years as head of pricing for Africa, client markets director for UK & Ireland, and most recently as global corporate actuary. Prior